Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 2,531 | 982 | N/A |
| Income taxes - deferred | 5,621 | N/A | N/A |
| Accounts receivable | -19,552 | -6,427 | N/A |
| Accounts payable and accrued liabilities | N/A | 6,885 | N/A |
| Other Working Capital | -50,236 | -11,225 | 34 |
| Other Operating Activity | 36,371 | -1,328 | -136 |
| Operating Cash Flow | $-25,265 | $-11,113 | $-102 |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | -108 | -31 | N/A |
| Other Investing Activity | -32,438 | -14,572 | 0 |
| Investing Cash Flow | $-32,546 | $-14,603 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 6,000 | N/A |
| Debt Issued | 9,700 | 0 | N/A |
| Debt Repayment | -6,199 | N/A | N/A |
| Common Stock Issued | 70,827 | 24,296 | 163 |
| Other Financing Activity | 14,171 | 768 | 0 |
| Financing Cash Flow | $88,499 | $31,064 | $163 |
| Exchange Rate Effect | 89 | 9 | N/A |
| Beginning Cash Position | 7,850 | 2,493 | 400 |
| End Cash Position | 38,627 | 7,850 | 461 |
| Net Cash Flow | $30,688 | $5,348 | $61 |
| Free Cash Flow | |||
| Operating Cash Flow | -25,265 | -11,113 | -102 |
| Capital Expenditure | -32,438 | -14,572 | N/A |
| Free Cash Flow | -57,703 | -25,685 | -102 |